The Endobronchial Ultrasound Biopsy Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Transbronchial Aspiration Needles, Spray Catheters, Others), By Application (Cancer Diagnosis, Infection Diagnosis, Others).
In 2025, the market for endobronchial ultrasound (EBUS) biopsy addresses the critical role of minimally invasive diagnostic techniques in pulmonary medicine, offering advanced bronchoscopy systems, ultrasound probes, and biopsy needles for the evaluation and sampling of mediastinal and hilar lymph nodes, lung masses, and lesions adjacent to the tracheobronchial tree. Endobronchial ultrasound combines bronchoscopy with real-time ultrasound imaging, allowing pulmonologists and thoracic surgeons to visualize and access structures within the mediastinum and lungs with high precision and accuracy. EBUS biopsy procedures enable the sampling of tissue specimens for cytological and histological analysis, aiding in the diagnosis and staging of lung cancer, tuberculosis, sarcoidosis, and other pulmonary diseases. EBUS-guided transbronchial needle aspiration (TBNA) and transbronchial lung biopsy (TBLB) techniques offer advantages in terms of diagnostic yield, safety, and patient comfort compared to traditional surgical biopsy methods, reducing the need for invasive procedures and hospitalization. With a focus on diagnostic accuracy, procedural efficiency, and patient safety, EBUS biopsy systems undergo continuous improvement, imaging enhancements, and needle design optimization to improve tissue sampling adequacy, lesion localization, and diagnostic yield in pulmonary medicine. Moreover, with advancements in image-guided navigation, robotic assistance, and molecular diagnostics, the EBUS biopsy market continues to innovate, offering integrated solutions, personalized treatment algorithms, and precision medicine approaches for optimizing diagnostic accuracy, therapeutic decision-making, and patient outcomes in the management of lung diseases and thoracic malignancies.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossACE Medical Devices Pvt. Ltd, Boston Scientific Corp, Clinodevices B.V., CONMED Corp, Cook Group Inc, END-FLEX GmbH, Medi-Globe Corp, Medtronic plc, Micro-Tech (Nanjing) Co. Ltd, Olympus Corp, and Others.
A prominent trend in the endobronchial ultrasound biopsy market is the expansion of minimally invasive diagnostic techniques for pulmonary diseases. Endobronchial ultrasound (EBUS) biopsy has emerged as a valuable tool for obtaining tissue samples from within the airways and adjacent structures, enabling accurate diagnosis of lung nodules, mediastinal masses, and lymph node abnormalities. With a growing emphasis on early detection and precise characterization of pulmonary lesions, EBUS biopsy offers advantages such as real-time visualization, targeted sampling, and reduced procedural risks compared to traditional biopsy methods. This trend reflects the increasing adoption of minimally invasive procedures in respiratory medicine, driving market growth and technological advancements in EBUS biopsy instrumentation and imaging modalities.
A key driver for the endobronchial ultrasound biopsy market is the rising incidence of lung cancer and respiratory diseases worldwide. Lung cancer remains one of the leading causes of cancer-related mortality globally, with a growing burden of disease attributed to factors such as smoking, air pollution, and occupational exposures. Additionally, respiratory diseases such as tuberculosis, sarcoidosis, and lymphoma require accurate diagnosis and staging to guide treatment decisions and improve patient outcomes. Endobronchial ultrasound biopsy plays a critical role in the diagnostic workup of pulmonary lesions, offering high diagnostic yield, minimal invasiveness, and rapid results, thereby facilitating timely intervention and personalized treatment strategies. The increasing prevalence of lung cancer and respiratory diseases drives demand for EBUS biopsy procedures, supporting market growth and the adoption of EBUS biopsy technologies in clinical practice.
An opportunity for innovation and market expansion in the endobronchial ultrasound biopsy market lies in the integration of multimodal imaging and interventional techniques. By combining EBUS with advanced imaging modalities such as positron emission tomography-computed tomography (PET-CT), magnetic resonance imaging (MRI), and navigational bronchoscopy, clinicians can enhance lesion localization, improve diagnostic accuracy, and optimize treatment planning for patients with complex pulmonary conditions. Additionally, there is an opportunity to integrate EBUS with therapeutic interventions such as bronchoscopic ultrasound-guided transbronchial needle aspiration (TBNA), endobronchial laser therapy, and radiofrequency ablation, enabling comprehensive management of benign and malignant airway lesions. This opportunity aligns with the trend towards personalized medicine, precision oncology, and minimally invasive procedures, driving innovation and market differentiation in the integrated EBUS biopsy segment.
The Transbronchial Aspiration Needles segment within the Endobronchial Ultrasound Biopsy market is experiencing rapid growth due to several factors driving the demand for minimally invasive diagnostic procedures in the field of respiratory medicine. Transbronchial aspiration needles are integral components of endobronchial ultrasound (EBUS) procedures, allowing clinicians to obtain tissue samples from the mediastinal and hilar lymph nodes, lung parenchyma, and adjacent structures under real-time ultrasound guidance. These needles facilitate the diagnosis of various pulmonary conditions, including lung cancer, infections, and inflammatory diseases, by enabling the collection of cytological and histological specimens for pathological analysis. With the increasing prevalence of lung cancer and the growing demand for early and accurate diagnosis, there is a rising need for minimally invasive biopsy techniques that provide high diagnostic yield while minimizing patient discomfort and procedural complications. Transbronchial aspiration needles offer advantages such as precise tissue targeting, real-time visualization, and reduced risk of complications compared to traditional biopsy methods such as transthoracic needle aspiration and surgical biopsy. Additionally, advancements in EBUS technology, including the development of flexible and steerable needles, improve the accessibility and maneuverability of transbronchial aspiration procedures, further driving their adoption in clinical practice. As healthcare providers increasingly prioritize minimally invasive approaches to respiratory diagnosis and staging, the Transbronchial Aspiration Needles segment is poised for significant growth in the Endobronchial Ultrasound Biopsy market, contributing to improved patient outcomes and enhanced diagnostic accuracy in pulmonary medicine.
By Product
By Application
Geographical Analysis
*List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Endobronchial Ultrasound Biopsy Market, encompassing current market size, growth trends, and forecasts till 2034.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Endobronchial Ultrasound Biopsy Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2025 Endobronchial Ultrasound Biopsy Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Endobronchial Ultrasound Biopsy Market Size Outlook, $ Million, 2021 to 2034
3.2 Endobronchial Ultrasound Biopsy Market Outlook by Type, $ Million, 2021 to 2034
3.3 Endobronchial Ultrasound Biopsy Market Outlook by Product, $ Million, 2021 to 2034
3.4 Endobronchial Ultrasound Biopsy Market Outlook by Application, $ Million, 2021 to 2034
3.5 Endobronchial Ultrasound Biopsy Market Outlook by Key Countries, $ Million, 2021 to 2034
4 Market Dynamics
4.1 Key Driving Forces of Endobronchial Ultrasound Biopsy Industry
4.2 Key Market Trends in Endobronchial Ultrasound Biopsy Industry
4.3 Potential Opportunities in Endobronchial Ultrasound Biopsy Industry
4.4 Key Challenges in Endobronchial Ultrasound Biopsy Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Endobronchial Ultrasound Biopsy Market Share by Company (%), 2025
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Endobronchial Ultrasound Biopsy Market Outlook by Segments
7.1 Endobronchial Ultrasound Biopsy Market Outlook by Segments, $ Million, 2021- 2034
By Product
Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Others
By Application
Cancer Diagnosis
Infection Diagnosis
Others
8 North America Endobronchial Ultrasound Biopsy Market Analysis and Outlook To 2034
8.1 Introduction to North America Endobronchial Ultrasound Biopsy Markets in 2024
8.2 North America Endobronchial Ultrasound Biopsy Market Size Outlook by Country, 2021-2034
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Endobronchial Ultrasound Biopsy Market size Outlook by Segments, 2021-2034
By Product
Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Others
By Application
Cancer Diagnosis
Infection Diagnosis
Others
9 Europe Endobronchial Ultrasound Biopsy Market Analysis and Outlook To 2034
9.1 Introduction to Europe Endobronchial Ultrasound Biopsy Markets in 2024
9.2 Europe Endobronchial Ultrasound Biopsy Market Size Outlook by Country, 2021-2034
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Endobronchial Ultrasound Biopsy Market Size Outlook by Segments, 2021-2034
By Product
Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Others
By Application
Cancer Diagnosis
Infection Diagnosis
Others
10 Asia Pacific Endobronchial Ultrasound Biopsy Market Analysis and Outlook To 2034
10.1 Introduction to Asia Pacific Endobronchial Ultrasound Biopsy Markets in 2024
10.2 Asia Pacific Endobronchial Ultrasound Biopsy Market Size Outlook by Country, 2021-2034
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Endobronchial Ultrasound Biopsy Market size Outlook by Segments, 2021-2034
By Product
Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Others
By Application
Cancer Diagnosis
Infection Diagnosis
Others
11 South America Endobronchial Ultrasound Biopsy Market Analysis and Outlook To 2034
11.1 Introduction to South America Endobronchial Ultrasound Biopsy Markets in 2024
11.2 South America Endobronchial Ultrasound Biopsy Market Size Outlook by Country, 2021-2034
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Endobronchial Ultrasound Biopsy Market size Outlook by Segments, 2021-2034
By Product
Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Others
By Application
Cancer Diagnosis
Infection Diagnosis
Others
12 Middle East and Africa Endobronchial Ultrasound Biopsy Market Analysis and Outlook To 2034
12.1 Introduction to Middle East and Africa Endobronchial Ultrasound Biopsy Markets in 2024
12.2 Middle East and Africa Endobronchial Ultrasound Biopsy Market Size Outlook by Country, 2021-2034
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Endobronchial Ultrasound Biopsy Market size Outlook by Segments, 2021-2034
By Product
Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Others
By Application
Cancer Diagnosis
Infection Diagnosis
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
ACE Medical Devices Pvt. Ltd
Boston Scientific Corp
Clinodevices B.V.
CONMED Corp
Cook Group Inc
END-FLEX GmbH
Medi-Globe Corp
Medtronic plc
Micro-Tech (Nanjing) Co. Ltd
Olympus Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Biopsy Forceps
Cytology Brushes
Biopsy Needles
Transbronchial Aspiration Needles
Spray Catheters
Others
By Application
Cancer Diagnosis
Infection Diagnosis
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The Global Endobronchial Ultrasound Biopsy Market Size is estimated at $811.5 Million in 2025 and is forecast to register an annual growth rate (CAGR) of 5.1% to reach $1269.7 Million by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
ACE Medical Devices Pvt. Ltd, Boston Scientific Corp, Clinodevices B.V., CONMED Corp, Cook Group Inc, END-FLEX GmbH, Medi-Globe Corp, Medtronic plc, Micro-Tech (Nanjing) Co. Ltd, Olympus Corp
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume